Patient Guide: Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 196 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT02453282
Status: ACTIVE_NOT_RECRUITING
Condition: Non-Small-Cell Lung Carcinoma NSCLC
Phase: PHASE3

Find a Study Location Near You

This study is available at 196 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Scottsdale, Arizona
  • Tucson, Arizona
  • Yuma, Arizona
  • • And 193 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily